PLP1 gene analysis in 88 patients with leukodystrophy

Area of Science:

• Genetics
• Neurology
• Molecular Biology

Background:

• Pelizaeus-Merzbacher disease (PMD) is a dysmyelinating disorder primarily affecting the central nervous system.
• Mutations in the PLP1 gene are the most common cause of PMD, acting through diverse molecular mechanisms.
• PMD exhibits a broad clinical spectrum.

Purpose of the Study:

• To investigate the spectrum of PLP1 gene mutations in male patients with leukodystrophy.
• To identify the frequency of PLP1 gene mutations in a cohort of patients with leukodystrophy.

Main Methods:

• Analysis of the PLP1 gene in 88 male patients with leukodystrophy using Multiplex Ligation-dependent Probe Amplification (MLPA) and DNA sequencing.
• Gene dosage analysis for PLP1 duplications using array Comparative Genomic Hybridization (array-CGH).
• Customized array-CGH at Xq22.2 to detect complex rearrangements in the PLP1 gene region.

Main Results:

• Identified PLP1 gene mutations in 21 out of 88 patients (approximately 24%).
• Detected various mutation types, including duplications, large and small deletions, and point mutations.
• Complex rearrangements within the PLP1 gene region were identified using customized array-CGH.

Conclusions:

• Mutations in the PLP1 gene are a significant cause of PMD in patients with leukodystrophy.
• The study highlights the utility of MLPA and array-CGH in detecting diverse PLP1 mutations.
• Understanding the molecular basis of PMD is crucial for diagnosis and potential therapeutic strategies.